Go to deals
Consumer & Retail | Private Equity

Enaltus, LLC has sold its brand ScarAway® to Perrigo Company plc

August 2015 — Enaltus, LLC, a portfolio company of HealthEdge Investment Partners, LLC, has sold ScarAway®, a leading US over-the-counter (OTC) scar management brand, to Perrigo Company plc. Financial details have not been disclosed.

ScarAway® is a market leader in the scar management category in the OTC consumer channel. It is the fastest-growing brand in the category and is currently the number one 100% silicone scar treatment brand and the number two brand in the overall consumer scar category in the US. ScarAway® provides a complete range of scar management solutions, including gels, serum and long and short fabric-backed silicone sheets. The brand has distribution across all retailers in the drug, mass, food, specialty and e-commerce channels, with a presence in more than 35,000 doors in the US.

Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company plc (NYSE:PRGO), together with its subsidiaries, develops, manufactures, markets, and distributes OTC consumer goods and pharmaceutical products worldwide. It offers its products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company sells its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, parapharmacies and hospitals as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America.

Founded in 1995 and based in Suwanee, Georgia, Enaltus develops, manufactures and markets skincare products for professional and consumer markets primarily for mothers and babies in the US and internationally. The company’s products include Kelo-cote, a topical silicone gel and spray for the treatment and prevention of abnormal scars, including hypertrophic scars and keloids; bioCorneum, a silicone treatment for minimizing the appearance of scars; Belli, a skincare cosmetic for expecting and nursing mothers, and babies; and CapriClear Moisturizing Spray, a solution that provides relief from dry, flaky, and irritated skin. Enaltus also offers Arnika Forte, a natural supplement for recovering from bruising, swelling, and pain associated with soft tissue injuries. The company serves physicians, plastic surgeons, dermatologists, OB/GYN’s and others. It offers its products directly to physicians and consumers as well as through national and independent retailers.

Our role in the transaction

Oaklins' team in Los Angeles acted as advisor to Enaltus, LLC in this transaction.

Parties

Talk to the deal team

Steven Davis

Managing Director
Los Angeles, United States
Oaklins Intrepid

Brian Levin

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Private Equity | Business Support Services

Nymann Kloak- & Miljøservice has been acquired by Serwent Group

Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.

Learn more
Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Private Equity | Healthcare

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy

Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.

Learn more
GP-Connect has joined forces with Transformation Capital to accelerate growth
Private Equity | Business Support Services

GP-Connect has joined forces with Transformation Capital to accelerate growth

Transformation Capital, a Netherlands-based investment firm, has joined forces with GP-Connect, a leading international secondment platform with specialized brands serving the hospitality, IT, skilled labor, technical services and dental sectors. As part of the transaction, GP-Connect welcomes Transformation Capital as its new shareholder to support the company’s next phase of growth, while the founders and existing shareholders will remain actively involved. The partnership will focus on executing a targeted buy-and-build strategy, expanding the business internationally and further strengthening GP-Connect’s portfolio.

Learn more